STAAR Surgical Past Earnings Performance

Past criteria checks 2/6

STAAR Surgical has been growing earnings at an average annual rate of 29.9%, while the Medical Equipment industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 20.6% per year. STAAR Surgical's return on equity is 5.5%, and it has net margins of 6.6%.

Key information

29.9%

Earnings growth rate

28.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate20.6%
Return on equity5.5%
Net Margin6.6%
Next Earnings Update08 May 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How STAAR Surgical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:SR3 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
29 Dec 233222117944
29 Sep 233101918043
30 Jun 233062517141
31 Mar 232953215938
30 Dec 222844014336
30 Sep 222793813335
01 Jul 222623412534
01 Apr 222432911734
31 Dec 212302811234
01 Oct 212172310434
02 Jul 21206219634
02 Apr 21179118433
01 Jan 2116368032
02 Oct 2015697830
03 Jul 2014877628
03 Apr 20153137727
03 Jan 20150147525
27 Sep 1914297224
28 Jun 1913586923
29 Mar 1912966722
28 Dec 1812456322
28 Sep 1811846022
29 Jun 1810935421
30 Mar 189714921
29 Dec 1791-24820
29 Sep 1788-24519
30 Jun 1784-54619
31 Mar 1784-64618
30 Dec 1682-125021
30 Sep 1681-135120
01 Jul 1680-135019
01 Apr 1678-124918
01 Jan 1677-74315
02 Oct 1573-84214
03 Jul 1572-94213
03 Apr 1574-94312
02 Jan 1575-84412
03 Oct 1477-74611
04 Jul 1476-34610
04 Apr 1474-1439
03 Jan 14720417
27 Sep 13700387
28 Jun 1368-1386

Quality Earnings: SR3 has high quality earnings.

Growing Profit Margin: SR3's current net profit margins (6.6%) are lower than last year (13.9%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SR3's earnings have grown significantly by 29.9% per year over the past 5 years.

Accelerating Growth: SR3's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: SR3 had negative earnings growth (-46.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-9.8%).


Return on Equity

High ROE: SR3's Return on Equity (5.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.